Evidence map›Paper›PMID 31769642›Full record

ArticleTurkish journal of medical sciences2020

Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality

Tarkan Özdemir, Ipek Candemir, Pinar Ergün, Mustafa Hamidullah Türkkani, Orhan Koç

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tarkan ÖzdemirDepartment of Pulmonary Medicine, University of Health Sciences Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, TurkeyORCID 0000-0002-9344-7586
Ipek CandemirDepartment of Pulmonary Medicine, University of Health Sciences Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, TurkeyORCID 0000-0002-9877-3516
Pinar ErgünDepartment of Pulmonary Medicine, University of Health Sciences Atatürk Chest Diseases and Chest Surgery Education and Research Hospital, Ankara, TurkeyORCID 0000-0001-8169-4689
Mustafa Hamidullah TürkkaniDepartment of Pulmonary Medicine, Sincan State Hospital, Ankara, TurkeyORCID 0000-0003-1503-7343
Orhan KoçDepartment of General Directorate for Disabled and Elderly Services, Ministry of Family and Social Policies, Ankara, TurkeyORCID 0000-0002-6875-5018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pulmonary rehabilitation (PR) is an effective, evidenced-based treatment. Despite its proven effect, it is still underused. The aim of this study was to present the number of patients with chronic obstructive pulmonary disease (COPD) who underwent PR, general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was performed between 2008 and 2016 in Turkey. Materials and methods: The documents were obtained from Turkish Institution of Social Insurance. Ages, sexes, and numbers of patients with COPD who underwent PR between 2008 and 2016 were recorded. The number of patients with COPD who had been prescribed PR by physicians and the type of hospitals in which these patients underwent PR were identified. The general annual and the general total mortality rates between 2008 and 2016 among patients with COPD who underwent PR in 2008 were also determined. Results: The mean age ranges of patients with COPD who underwent PR were 67.4 ± 12.3 to 72.0 ± 13.2 years, and 62.2% (n = 60,852) of patients were male. The number of patients increased progressively from 3,214 to 18,664. The rate of patients prescribed PR programs between 2008 and 2016 was between 0.32% and 0.59% among all registered patients with COPD. Between 52.0% and 94.8% (5,488/10,549 and 16,792/17,707 patients, respectively) of the programs were prescribed by a pulmonologist, and 62.9% (n = 62,613) of patients received PR in secondary public hospitals. The general annual mortality rates were between 6.2% and 11.1% (115/1,855 and 358/3,214 patients) in patients who underwent PR in 2008, and the general total mortality rate was 52.8% (1,696/3,214 patients) over the 9-year period in the same patient group. Conclusion: PR was still an underutilized approach in Turkey between 2008 and 2016. The awareness of PR should be increased in our country. In order to achieve this, we think that PR should be within the scope of health policies.

Indexed as

AdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSurvival RateTurkeychronic obstructive pulmonary diseasePulmonary rehabilitationpulmonologist

Identifiers

PMID31769642
PMCPMC7080365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.